Bristol-Myers Squibb Company
BMY
$59.01
-$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 48.30B | 47.44B | 46.51B | 45.53B | 45.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.30B | 47.44B | 46.51B | 45.53B | 45.01B |
| Cost of Revenue | 11.95B | 11.44B | 11.08B | 10.92B | 10.52B |
| Gross Profit | 36.35B | 35.99B | 35.43B | 34.62B | 34.49B |
| SG&A Expenses | 7.82B | 8.03B | 7.89B | 7.88B | 7.68B |
| Depreciation & Amortization | 8.87B | 9.46B | 9.31B | 9.15B | 9.05B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.42B | 38.40B | 37.57B | 37.20B | 36.36B |
| Operating Income | 9.88B | 9.03B | 8.94B | 8.33B | 8.65B |
| Income Before Tax | -8.38B | -6.88B | -6.42B | -5.85B | 8.44B |
| Income Tax Expenses | 554.00M | 367.00M | 109.00M | 289.00M | 400.00M |
| Earnings from Continuing Operations | -8.93K | -7.25K | -6.53K | -6.14K | 8.04K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -11.00M | -13.00M | -13.00M | -15.00M |
| Net Income | -8.95B | -7.26B | -6.54B | -6.15B | 8.03B |
| EBIT | 9.88B | 9.03B | 8.94B | 8.33B | 8.65B |
| EBITDA | 19.45B | 19.21B | 18.95B | 18.17B | 18.42B |
| EPS Basic | -4.43 | -3.59 | -3.25 | -3.09 | 3.87 |
| Normalized Basic EPS | 3.05 | 3.02 | 3.07 | 2.95 | 3.07 |
| EPS Diluted | -4.43 | -3.60 | -3.26 | -3.10 | 3.86 |
| Normalized Diluted EPS | 3.04 | 3.02 | 3.07 | 2.94 | 3.05 |
| Average Basic Shares Outstanding | 8.11B | 8.11B | 8.13B | 8.20B | 8.28B |
| Average Diluted Shares Outstanding | 8.12B | 8.12B | 8.15B | 8.22B | 8.31B |
| Dividend Per Share | 2.42 | 2.40 | 2.37 | 2.34 | 2.31 |
| Payout Ratio | -54.35% | -66.20% | -73.08% | -77.42% | 59.12% |
